Bone Marrow Transplant Market

Bone Marrow Transplant Market Size Survey Report – In a Glance

As per the survey report on global Bone Marrow Transplant market, the market is projected to foresee a CAGR of CAGR value 3.5% between 2024-2033, and further generate a market size of USD 15.2 billion revenue by the end of 2033. In the year 2024, the market size was valued at USD 11.2 billion revenue.

• The global Bone Marrow Transplant market is projected to grow on account of the surging prevalence of blood cancer and other blood-related diseases.
• In Japan, the Bone Marrow Transplant market growth can be attributed to the enhanced supportive care and post-transplant therapies.
• KDMI analyst’s growth analysis foresees high cost associated with BMT to challenge the market growth.
• North America, having the highest market share in the Bone Marrow Transplant market, is projected to dominate the global market.

Bone Marrow Transplant Market Analysis

Bone marrow transplant (BMT) is a surgical procedure where a damaged or diseased bone marrow is replaced with healthy and functional stem cells. Over a long period, BMT has been effectively utilized to treat diseases like leukemias, lymphomas, aplastic anemia, immune deficiency disorders, and some general blood cancers. Lately, the surging prevalence of blood cancer and other blood-related diseases is helping the bone marrow transplant market to flourish at an accelerated pace. Based on the survey, around 59,610 people are likely to be diagnosed with leukemia, and around 23,710 people are expected to die from leukemia in 2023. Furthermore, more or less 35.9 percent more males than females are battling with leukemia. Merck Millipore Corporation, Sanofi-Aventis LLC., and STEMCELL Technologies are some of the significant parties in the global market for Bone Marrow Transplant.

Analyst’s Observation on Japan Bone Marrow Transplant Market Survey

In Japan, the market growth for Bone Marrow Transplant can be attributed to the enhanced supportive care and post-transplant therapies. One of the core areas of progress in supportive care for patients undergoing bone marrow transplant (BMT) is contamination control and preventive health measures with the help of some groundbreaking innovations like high-efficiency particulate air (HEPA) filtration systems and sterile barrier techniques. Cancer survival is gradually improving in Japan and it was reported that 8.16% of Japanese cancer patients had CV comorbidities but intensive and multimodal cancer therapy can manage the CV comorbidities and complications that are associated with both cancer and adverse effects of cancer therapy. FUJIFILM Corporation, Takeda Pharmaceutical Company Ltd., Santorius Japan are some of the significant parties in the market for Bone Marrow Transplant in Japan.

Bone Marrow Transplant Market Growth Driver and Challenges

Growth Driver

Growing demand for BMT due to higher success rate:

The growing demand for bone marrow transplantation (BMT) due to its higher success rate is a major catalyst for the bone marrow transplant market. The report says that about 80,000 allogeneic hematopoietic stem cell transplantations (allo-HCT) are conducted globally every year. As per received data from 341 centers for 21,775 patients who received other cellular therapies; 10,926 patients were treated for lymphoma and over 70% of activity is focused on the use of CAR-T for hematologic cancers.

Also, it has been found that the participating centers accrued >200 patients to trials in 2023, escalating the total to >16,800 patients from >100 centers since inception and data shows 5,557 new protocol-related biospecimen aliquots, bringing the total available biospecimens to 524,260.

Restraint

High cost associated with BMT:

A large portion of the population cannot afford bone marrow transplant (BMT) surgery due to the high expenditure associated with the treatment that is supposed to serve as a restricting factor for the bone marrow transplant market growth. Considering the rapidly rising healthcare costs, it is important to understand the economic costs of hematopoietic cell transplantation (HCT), a procedure that includes both bone marrow transplantation and peripheral blood stem cell transplantation (PBSCT). Studies have reported a wide range of costs for HCT, from $36 000 to $88 000 (USD) for a single autologous transplantation for the initial hospitalization, to $200 000 (USD) or more for a myeloablative allogeneic procedure that includes an unrelated donor.

Bone Marrow Transplant Market Segmentation

Our experts at KD Market Insights have segmented the global Bone Marrow Transplant market research report as:

Bone Marrow Transplant Market Regional Synopsis

The North America Bone Marrow Transplant market is majorly driven by the highest number of transplant centers, medical professionals and its excellent healthcare infrastructure. The United States is driving the bone marrow transplant (BMT) market in the region due to the higher incidence of blood cancers in the country and with its superior healthcare facilities, various large pharmaceuticals, advanced biotech businesses, significant resources, and innovations. According to various reports, someone in the US dies from blood cancer every 9 minutes and its statistical data shows that around 157 people succumb to death each day or more than six people every hour. Furthermore, hematological diseases like leukemia, lymphoma, and myeloma are predicted to cause the deaths of an estimated 57,260 people in the US in 2024. 

Asia Pacific is on the brink of emerging as the fastest-growing region of the bone marrow transplant (BMT) market where countries like India, China, and Japan are pouring significant resources to boost their healthcare framework and medical advancements.

As per our analysts at KD Market Insights, the following five players lead the North America Bone Marrow Transplant market growth:

• Hemacare Corporation
• STEMCELL Technologies
• Merck Mllipore Corporation
• Sanofi-Aventis LLC
• Novartis AG

Bone Marrow Transplant Market Competitive Landscape

Some of the key players who top the global Bone Marrow Transplant market share:

• Merck Millipore Corporation
• Sanofi-Aventis LLC.
• AllCells LLC.
• STEMCELL Technologies
• ATCC Inc.
• Hemacare Corporation
• Cellular Dynamics International
• ReachBio LLC.
• Conversant Bio ABM Inc.
• PromoCell GmbH
• Cruline Human biospecimen PRO
• Lifeline Cell Technology
• Mesoblast Ltd.

1. Executive Summary
   1. Market Overview
   2. Key Findings
   3. Market Trends
   4. Market Outlook
2. Introduction
   1. Scope of the Report
   2. Research Methodology
   3. Definitions and Assumptions
   4. Acronyms and Abbreviations
3. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
   4. Challenges
4. Global Bone Marrow Transplant Market
   1. Market Overview
   2. Market Size and Forecast
   3. Market Segmentation
      1. By Transplant type
      2. By Disease indication
      3. By End-user
      4. By Region
5. Market Segmentation by Transplant type
   1. 1. Autologous Transplant
      2. Allogenic Transplant
      3. Others
6. Market Segmentation by Disease indication
   1. 1. Leukemia
      2. Lymphoma
      3. Myeloma
      4. Myelodysplasia
      5. Myeloproliferative neoplasms
      6. Aplastic anemia
      7. Solid tumors
      8. Sickle cell anemia
      9. Thalessemia
      10. Others
7. Market Segmentation by End-user
   1. 1. Hospitals
      2. Multispecialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
8. Regional Analysis
   1. North America
      1. United States
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      2. Canada
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      3. Mexico
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
   2. Europe
      1. United Kingdom
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      2. Germany
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      3. France
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      4. Italy
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      5. Spain
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      6. Rest of Europe
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
   3. Asia Pacific
      1. China
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      2. Japan
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      3. India
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      4. Australia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
         4. South Korea
         5. Market Size and Forecast
         6. Key Trends and Developments
         7. Market Analysis by Transplant type, Disease indication, and End-user
      5. Rest of Asia Pacific
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
   4. Latin America
      1. Brazil
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      2. Argentina
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      3. Colombia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      4. Rest of Latin America
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
   5. Middle East & Africa
      1. South Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      2. Saudi Arabia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      3. UAE
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
      4. Rest of Middle East & Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Transplant type, Disease indication, and End-user
9. Competitive Landscape
   1. Market Share Analysis
   2. Company Profiles
   3. Medtronic (Ireland)
   4. IBM
   5. Apple Inc.
   6. Siemens Medical Solutions
   7. Pepperl+Fuchs
   8. Cisco
   9. GE Healthcare
10. Strategic Recommendations
11. Appendix
    1. List of Tables
    2. List of Figures
12. References